Key Developments and Trends Steering the Antisense & RNAi Therapeutics Market Forward: Strategic Collaborations Driving Innovation In The Antisense & RNAI Therapeutics Market
Discover trends, market shifts, and competitive outlooks for the antisense & rnai therapeutics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
#How Has The Antisense & RNAi Therapeutics Market Size Shifted, And What Is the Outlook Through 2034?
The market for antisense & RNAi therapeutics has experienced quick expansion in recent years. Its size is expected to escalate from $1.75 billion in 2024 to $1.94 billion in 2025, with a compound annual growth rate (CAGR) of 11.2%. This increasing trend in the historic period can be traced back to increased funding, technological advancements, surge in healthcare spending, quick rise of the aging population, and economic progression in emerging markets.
In the coming years, the antisense & RNAi therapeutics market is predicted to witness significant growth, reaching $3.18 billion by 2029 with a compound annual growth rate (CAGR) of 13.1%. This projected expansion during the forecast period could be credited to broader healthcare accessibility, an escalating incidence of cancer, and a growing demand for antisense and RNAi therapeutics triggered by the COVID-19 pandemic. The prediction period is likely to observe key trends including targeted research and development efforts for orphan disease RNA therapeutics, application of nanoparticles, invention of new and enhanced antisense and RNAi therapeutics, and partnerships with other corporations to brainstorm innovative products and boost revenue.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3389&type=smp
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theAntisense & RNAi Therapeutics Market?
The increasing incidence of conditions like coronary artery diseases, neurodegenerative disorders, and infectious diseases is expected to stimulate demand for the antisense & RNAi therapeutics market. Techniques that suppress genes, like RNA interference and antisense oligonucleotides, are employed to treat a range of neurodegenerative diseases by rectifying mutant genes. For instance, data from a report by the American Heart Association, a US-based entity, revealed that there was a rise to 233.3 per 100,000 in the age-adjusted death rate from cardiovascular diseases in January 2024, signifying a 4.0% increase from the preceding year. Consequently, the escalating prevalence of various neurodegenerative diseases and infectious diseases is anticipated to propel the growth of the antisense & RNAi therapeutics market.
Which Segments in the Antisense & RNAi Therapeutics Offer the Most Growth?
The antisense & RNAi therapeutics market covered in this report is segmented –
1) By Technology: RNA Interference, Antisense RNA
2) By Route Of Administration: Intravenous Injections, Intra-dermal Injections, Other Delivery Methods
3) By Indication: Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Neurological Disorders, Infectious Diseases, Other Indications
Subsegments:
1) By RNA Interference (RNAi): Small Interfering RNA (siRNA), Short Hairpin RNA (shRNA), Dicer-substrate siRNA, MicroRNA (miRNA) Based Therapeutics
2) By Antisense RNA: Antisense Oligonucleotides (ASOs), Morpholino Oligomers, Locked Nucleic Acids (LNAs), Gapmer Antisense Oligonucleotides
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=3389&type=smp
What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theAntisense & RNAi Therapeutics Market?# Market?
North America was the largest region in the antisense & RNAi therapeutics market in 2024. The regions covered in the antisense & RNAi therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Are the Current Market Growth and Trends in the Antisense & RNAi Therapeutics Industry?
Large corporations involved in the antisense and RNAi therapeutics market are implementing strategic maneuvers like partnerships and collaborations to stay afloat in an intensifying competitive field. This business tactic requires at least two companies to work jointly towards a mutual goal. For instance, Orbit Discovery Limited, a company based in the US and specializing in the identification of peptides, formed a partnership with SanegeneBio Inc., a UK-based firm that is developing unique RNAi-based medicine. This partnership was initiated in January 2023 with the goal being to identify tissue-specific RNA therapeutics to enhance gene knockdown efficiency, subsequently contributing to the development of advanced RNAi therapeutics. Under this agreement, both companies will undertake hit identification and cell-based internalization studies, with Sanegene retaining the ability to further develop the identified potential hits using Orbit’s exclusive rapid peptide discovery technology. Orbit Discovery’s novel peptide display engine allows for large-scale peptide library screening, hastening the identification of relevant peptide leads using affinity and function screens.
View the full report here:
What Are the Key Elements That Define the Antisense & RNAi Therapeutics Market?
Antisense therapy refers to the selective, sequence-specific suppression of gene expression by single-stranded DNA oligonucleotides. Contrarily, RNA interference (RNAi) is activated by double-stranded RNA (dsRNA) and results in the sequence-specific mRNA degradation of single-stranded target RNAs.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3389
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
